Keyphrases
Aberrant Signaling
20%
Acute Lymphoblastic Leukemia
20%
Antileukemic Activity
20%
BCR-ABL
100%
Cell Resistance
20%
Chronic Myeloid Leukemia
40%
Deregulation
20%
JNK Mitogen-activated Protein Kinases
20%
Leukemia
20%
Leukemic Cells
20%
Leukemogenesis
20%
Mammalian Target of Rapamycin (mTOR)
100%
Mitogen-activated Protein Kinase
100%
P38 Mitogen-activated Protein Kinase (p38 MAPK)
20%
Ph+ Acute Lymphoblastic Leukemia
20%
Philadelphia Chromosome
20%
Potential Therapeutics
20%
Recent Advances
20%
Selective Inhibitor
20%
Signaling Cascades
20%
Therapeutic Targeting
20%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
40%
Chronic Myelogenous Leukemia
40%
Kinase Signaling
40%
Leukemia
20%
Leukemogenesis
20%
Mechanistic Target of Rapamycin
100%
Mitogen Activated Protein Kinase P38
20%
Mitogen-Activated Protein Kinase
100%
Philadelphia 1 Chromosome
20%
Stress Activated Protein Kinase
20%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Lymphoblastic Leukemia
40%
Chronic Myeloid Leukemia
40%
Leukemia
20%
Leukemogenesis
20%
Mammalian Target of Rapamycin
100%
Mitogen Activated Protein Kinase
100%
Mitogen Activated Protein Kinase P38
20%
Philadelphia 1 Chromosome
20%
Stress Activated Protein Kinase
20%
Biochemistry, Genetics and Molecular Biology
C-Jun N-Terminal Kinases
20%
Mechanistic Target of Rapamycin
100%
Mitogen-Activated Protein Kinase
100%
Myeloid
40%
P38 Mitogen-Activated Protein Kinases
20%
Philadelphia Chromosome
20%